Title : Vildagliptin: a novel DPP-4 inhibitor with pancreatic islet enhancement activity for treatment of patients with type 2 diabetes.

Pub. Date : 2006 Aug

PMID : 16969429






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Vildagliptin: a novel DPP-4 inhibitor with pancreatic islet enhancement activity for treatment of patients with type 2 diabetes. Vildagliptin dipeptidyl peptidase 4 Homo sapiens
2 Vildagliptin is a potent, orally active, highly selective DPP-4 inhibitor that enhances the antidiabetic actions of the incretins. Vildagliptin dipeptidyl peptidase 4 Homo sapiens